IP Library Granted Patent US 9,066,989
Granted Patent B2
US 9,066,989 · App. 14/280,512 · Granted Jun 30, 2015

Silver containing wound dressing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,066,989
App. No.
14/280,512
Granted
Jun 30, 2015
Kind
B2
Abstract

A wound dressing having anti-microbial activity comprises a first fiber capable of bonding with silver (1) cations. The wound dressing comprises a blend of the first fiber to which silver (1) cations are bonded and a second fiber which is substantially free from silver. The wound dressing comprises from 0.01 to 5.0 percent by weight of silver (1) cations, based on the weight of fiber.

Claims (15)

1. A wound dressing comprising gel-forming fibers having ant-imicrobial activity, comprising a first fiber which is gel-forming and substantially insoluble in water having silver (I) cations bonded thereto and discoloring on exposure to light, wherein the wound dressing consists of a uniform blend of the first fiber and a second fiber of lyocell which is substantially free from silver, said wound dressing comprising from 0.01 to 5.0 percent by weight of silver (I) cations based on the total weight of first and second fibers, whereby the discoloration of the blend on exposure to light is lessened compared with the discoloration on exposure to light of a batch of the first fiber having the same average amount of silver cations present as is present in the blend.

2. A wound dressing according to claim 1 , which comprises from 0.01 to 4.0 percent by weight of silver (I) cations based on the total weight of first and second fibers.

3. A wound dressing according to claim 1 , which comprises from 0.25 to 3.0 percent by weight of silver (I) cations based on the total weight of first and second fibers.

4. A wound dressing according to claim 1 , wherein the first fiber is selected from a group consisting of a carboxymethylcellulose fiber, an alginate fiber, a chitosan fiber and a chitosan derivative fiber.

5. A wound dressing according to claim 4 , wherein the first fiber is a carboxymethylcellulose fiber and the wound dressing contains from 1.0 to 2.0 percent by weight of silver (I) cations, based on the weight of the fiber.

6. A wound dressing according to claim 4 , wherein the first fiber is an alginate fiber and the wound dressing contains from 0.25 to 0.75 percent by weight of silver (I) cations, based on the weight of the fiber.

7. A wound dressing according to claim 1 , wherein the second fiber contains no silver or low levels of silver such that it discolors to a degree which is not aesthetically objectionable.

8. A wound dressing according to claim 1 , wherein the second fiber contains no silver or low levels of silver such that it does not discolor at all.

9. A wound dressing according to claim 1 , wherein the ratio of the first fiber to the second fiber is in the range of from 5 to 20% by weight of the total weight of the fiber.

10. A wound dressing according to claim 1 , wherein the ratio of the first fiber to the second fiber is in the range of from 0.5 to 25% by weight of the total weight of the fiber.

11. A wound dressing according to claim 1 , wherein the first fiber includes at least 8% by weight, based on the weight of the fiber, of silver (I) cations.

12. A wound dressing according to claim 11 , wherein the first fiber is prepared using at least a 4% silver nitrate solution.

13. A wound dressing according to claim 1 , wherein the silver ions are chemically bonded to the first fiber.

14. A wound dressing according to claim 1 , wherein the silver ion are introduced into the first fiber by ion-exchange.

15. A wound dressing according to claim 1 , wherein the first fiber having silver (I) cations bonded thereto is pre-exposed to light prior to blending with the second fiber.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2019
From: WILMINGTON TRUST (LONDON) LIMITED
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 050831/0001 →
SECURITY AGREEMENT Recorded Nov 3, 2016
From: CONVATEC INC.; CONVATEC TECHNOLOGIES INC.; 180 MEDICAL, INC.; PRN MEDICAL SERVICES, LLC
To: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT
Reel/Frame 040552/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2015
From: WOODS, DAVID MALCOLM
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 034975/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2015
From: WOODS, DAVID MALCOLM
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 034637/0329 →